Income Taxes (Details Narrative) - USD ($) |
2 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|---|
Feb. 28, 2021 |
Feb. 24, 2021 |
Mar. 30, 2021 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Subsequent Event [Line Items] | |||||||
| Changes in valuation allowance | $ 545,000 | $ 213,000 | |||||
| Net operating loss ("NOL") carryforwards | 2,100,000 | ||||||
| Penalties and Interest Expense | 0 | 0 | |||||
| Proceeds from options exercise | 405,000 | ||||||
| Proceeds from loan | $ 193,625 | $ 684,580 | |||||
| Proceeds from sale of stock | $ 4,599,055 | $ 2,445,603 | |||||
| Subsequent Event [Member] | |||||||
| Subsequent Event [Line Items] | |||||||
| Proceeds from options exercise | $ 68,000 | ||||||
| Stock options issued | 45,625 | ||||||
| Proceeds from loan | $ 193,625 | ||||||
| Interest rate | 1.00% | ||||||
| Frequency of payment | 60 | ||||||
| Periodic payment | $ 3,300 | ||||||
| Sale of stock | 1,251,625 | ||||||
| Sale of stock, price per share | $ 4.00 | ||||||
| Proceeds from sale of stock | $ 4,600,000 | ||||||
| Exercise price | $ 4.00 | ||||||
| Additional sale of stock | 2,498,375 | ||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of the frequency of periodic payments (monthly, quarterly, annual). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the required periodic payments including both interest and principal payments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received from principal payments made on loans related to operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow from exercise of option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|